Some miRNAs with abnormal expression in tumor cells can regulate the surface expression of CTLA-4 in tumor-infiltrating T cells, thereby inhibiting the antitumor immune response mediated by T cells and promoting TIE (Table 5, Fig. 4). This evidence concerns the gene CTLA4 and neoplasm.